These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38506035)

  • 1. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
    Li X; He J; Ren X; Zhao H; Zhao H
    Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
    Guan X; Gu S; Yuan M; Zheng X; Wu J
    Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
    Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
    J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.
    Zhang Y; Tie Q; Bao Z; Shao Z; Zhang L
    Comput Math Methods Med; 2021; 2021():6468405. PubMed ID: 34812269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.
    Yang J; Yu H; Shen M; Wei W; Xia L; Zhao P
    Cancer Sci; 2014 Feb; 105(2):219-27. PubMed ID: 24262005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
    Lu P; Jiang Y; Xia Z
    Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J; Jiang C; Liu B; Fang S; Kuang M
    Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
    Bollaert E; Claus M; Vandewalle V; Lenglez S; Essaghir A; Demoulin JB; Havelange V
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4.
    Deng J; Wang H; Liang Y; Zhao L; Li Y; Yan Y; Zhao H; Zhang X; Zou F
    Cell Signal; 2023 Jan; 101():110517. PubMed ID: 36332797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
    Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.
    Xu K; Zhan Y; Yuan Z; Qiu Y; Wang H; Fan G; Wang J; Li W; Cao Y; Shen X; Zhang J; Liang X; Yin P
    Mol Ther; 2019 Oct; 27(10):1810-1824. PubMed ID: 31208913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells.
    Jin Y; Wang H; Zhu Y; Feng H; Wang G; Wang S
    Eur J Pharmacol; 2020 Jul; 878():173105. PubMed ID: 32278855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
    Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
    Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
    Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
    Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions Between
    Wang S; Cheng M; Zheng X; Zheng L; Liu H; Lu J; Liu Y; Chen W
    Onco Targets Ther; 2020; 13():13159-13170. PubMed ID: 33380806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.
    Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F
    World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
    Yao Y; Zhang C; Xiong Y; Han B; Gao X; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1022-1029. PubMed ID: 34308851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1.
    Xia M; Sheng L; Qu W; Xue X; Chen H; Zheng G; Chen W
    World J Surg Oncol; 2021 Jun; 19(1):174. PubMed ID: 34127010
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Yang J; Jiang X; Chen Y; Teng L
    Discov Med; 2023 Dec; 35(179):1167-1176. PubMed ID: 38058082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.